XML 41 R27.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue Recognition - Performance Obligation (Details) - Everest Medicines II Limited
$ in Millions
Apr. 29, 2019
USD ($)
Revenue Recognition, Milestone Method [Line Items]  
Remaining performance obligation $ 65.0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-07-01  
Revenue Recognition, Milestone Method [Line Items]  
Remaining performance obligation $ 65.0
Term of license agreement 15 years